The acquisition of respiratory management system developer Propeller Health will provide exits for McKesson, Aptar Pharma, Hikma, GlaxoSmithKline, Walgreens and 3M.

Propeller Health, a US-based digital respiratory therapeutics developer backed by multiple corporate investors, agreed to a $225m acquisition by connected medical devices provider ResMed yesterday. The deal is expected to close by the end of March 2019 and is subject to customary closing conditions. Founded in 2010, Propeller Health has created a system that consists…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.